Verition Fund Management
RYTM icon

Verition Fund Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Verition Fund Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,504
Closed -$482K – 3360
2025
Q4 		$482K Buy
+4,504
New +$478K ﹤0.01% 2680
2025
Q2 		– Sell
-4,424
Closed -$234K – 3830
2025
Q1 		$234K Sell
4,424
-3,613
-45% -$200K ﹤0.01% 2986
2024
Q4 		$450K Buy
+8,037
New +$444K ﹤0.01% 2545
2023
Q2 		– Sell
-77,228
Closed -$1.38M – 2493
2023
Q1 		$1.38M Buy
+77,228
New +$1.94M 0.02% 825

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Verition Fund Management's RYTM Position: Q1 2026 in Review

Verition Fund Management sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 4,504 shares — an estimated $482K sold.

Verition Fund Management first reported a position in RYTM in Q1 2023 and held it in 4 quarters. The position peaked at $1.38M in Q1 2023. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Verition Fund Management reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 4,504 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $482K.
  • Verition Fund Management first reported a position in Rhythm Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • Verition Fund Management's Rhythm Pharmaceuticals position peaked at $1.38M in Q1 2023.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.